Abstract Number:
1580
Submission Type:
Topic-Contributed Panel Session
Participants:
Umut Ozbek (1), Alison Motsinger-Reif (3), Daniel Schaid (4), Lon Cardon (5), Eleanor Feingold (6), Andrea Foulkes (2)
Institutions:
(1) Eli Lilly and Company, New York, NY, (2) Massachusetts General Hospital, N/A, (3) NIH, N/A, (4) Mayo Clinic, N/A, (5) The Jackson Laboratory, N/A, (6) Oregon State University, N/A
Chair:
Panelist(s):
Session Organizer:
Session Description:
Genetics and genomics opened a new era in science. With advancing technology in recent years, we have accessed much more data than we could imagine. Statisticians and data scientists have played a very important role from the beginning to make sense of those data, yet more statistical expertise is needed. In this panel, we will discuss the scientific evolution of statistical genetics and genomics, overview of what has been achieved and what is yet to achieve, statisticians' involvement in the field, and current medical applications with highly reputable statistical geneticists from academia, government, and industry.
Sponsors:
Caucus for Women in Statistics 2
Committee on Women in Statistics 1
Section on Statistics in Genomics and Genetics 3
Theme:
Statistics and Data Science: Informing Policy and Countering Misinformation
Yes
Applied
Yes
Estimated Audience Size
Small (<80)
I have read and understand that JSM participants must abide by the Participant Guidelines.
Yes
I understand and have communicated to my proposed speakers that JSM participants must register and pay the appropriate registration fee by June 1, 2024. The registration fee is nonrefundable.
I understand